View Author
paclitaxel patient cancer antibody plasma sample concentration protein glioma vector beads tumor pharmacokinetic level serum peptide result antigen ad 5-gfa study microsphere cpt -11 sequence adenoviru sparreboom expression value cremophor el docetaxel blood 5-gfa table infection fraction treatment method cremophor ad 35 disposition course assay infusion r 101933 carboxylated beads -11 multiplex onconeural metabolite glioma cells binding analysis mfi values penta-his beads penta-hi detection therapy cdr peptides carboxylated intensity adalimumab multiplex assay onconeural antibodies adenoviral administration serum samples 5.fib anti-dnp ratio non-speci fic background signal wtad 5 rotterdam control oncolytic netherland verweij paraneoplastic replication clearance phase
10 Most Recent Publications
|
Multiplex serology of paraneoplastic antineuronal antibodies
(Article)
Maat, P. Brouwer, E. Hulsenboom, E. Duijn, M.M. van Schreurs, M.W.J. Hooijkaas, H. Smitt, P.A. |
2013-03-21
|
|
An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions
(Article)
Dekker, L.J.M. Zeneyedpour, L. Brouwer, E. Duijn, M. Sillevis Smitt, P.A.E. Luider, T.M. |
2010-01-01
|
|
Comparison of carboxylated and Penta-His microspheres for semi-quantitative measurement of antibody responses to His-tagged proteins
(Article)
Verkaik, N.J. Brouwer, E. Hooijkaas, H. Belkum, A.F. van Wamel, W.J.B. van |
2008-06-01
|
|
Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)-selective oncolytic adenovirus
(Article)
Horst, M. ter Brouwer, E. Verwijnen, S.M. Rodijk, M. Jong, M. de Hoeben, R.C. Leeuw, B. de Smitt, P.S. |
2007-12-01
|
|
Human adenovirus type 35 vector for gene therapy of brain cancer: Improved transduction and bypass of pre-existing anti-vector immunity in cancer patients
(Article)
Brouwer, E. Havenga, M.J. Avezaat, C.J.J. Goudsmit, J. Smitt, P.S. Ophorst, O. Leeuw, B. de Gijsbers, L. Gillissen, G. Hoeben, R.C. Horst, M. ter Nanda, D. Dirven, C.M.F. |
2007-02-01
|
|
Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans
(Article)
Zuylen, L. van Verweij, J. Nooter, K. Brouwer, E. Stoter, G. Sparreboom, A. |
2000-01-01
|
|
Measurement of fraction unbound paclitaxel in human plasma
(Article)
Brouwer, E. Verweij, J. Bruijn, P. de Loos, W.J. Pillay, M. Buijs, D. Sparreboom, A. |
2000-01-01
|
|
Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications
(Article)
Sparreboom, A. Zuylen, L. van Brouwer, E. Loos, W.J. Bruijn, P. de Gelderblom, A.J. Pillay, M. Nooter, K. Stoter, G. Verweij, J. |
1999-04-01
|
|
Drug-administration sequence does not change pharmacodynamics and kinetics of irinotecan and cisplatin
(Article)
Jonge, M.J.A. de Verweij, J. Planting, A.S.Th. Burg, M.E.L. van der Stoter, G. Boer-Dennert, M.M. de Bruijn, P. de Brouwer, E. Vernillet, L. Sparreboom, A. |
1999-01-01
|
|
Disposition of [G-(3)H]paclitaxel and cremophor EL in a patient with severely impaired renal function
(Article)
Gelderblom, A.J. Verweij, J. Brouwer, E. Pillay, M. Bruijn, P. de Nooter, K. Stoter, G. Sparreboom, A. |
1999-01-01
|
